Close Menu

Google

New Verily Faces

The San Francisco Business Times examines Verily's latest hires.

Here's a Spot

Stat News examines ethical questions raised by Alphabet's Verily awarding a research contract to a clinic mostly owned by its CEO.

The Genome Analysis Toolkit is available on the Google cloud and will be launched on Amazon, Microsoft, and IBM's clouds and BaseSpace later this year.

On Their Way Out

Stat News looks into people departing Alphabet's life sciences company, Verily.

Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.

Alphabet is the world's most valuable company now, and its Verily healthcare subsidiary is close to being self-supporting.

For Truth

Google's Life Science Division has the new, though old fashioned-sounding, name of Verily, Stat News reports.

Developers of proposals selected for the NCI-funded Cancer Genomics Cloud pilots have kicked of various stages of platform testing ahead of the nine-month evaluation phase

Google's resources and approach are enticing academic life science researchers, Nature News reports.

Bill Maris, a managing partner at Google Ventures, argues that genetic information needs to be shared and isn't private anyway, Bloomberg Business reports.

Pages

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.